In vivo tracking of T cells in humans unveils decade-long survival and activity of genetically modified T memory stem cells

Two subsets of memory T lymphocytes with distinct homing potentials and effector functions

Sallusto, F., Lenig, D., Förster, R., Lipp, M., & Lanzavecchia, A. (1999) · Nature · doi:10.1038/44385 · Cited by 5,846

GREAT improves functional interpretation of cis-regulatory regions

McLean, C. Y., Bristor, D., Hiller, M., Clarke, S. L., Schaar, B. T., Lowe, C. B., Wenger, A. M., & Bejerano, G. (2010) · Nature Biotechnology · doi:10.1038/nbt.1630 · Cited by 4,502

A human memory T cell subset with stem cell–like properties

Gattinoni, L., Lugli, E., Ji, Y., Pos, Z., Paulos, C. M., Quigley, M. F., Almeida, J. R., Gostick, E., Yu, Z., Carpenito, C., et al. (2011) · Nature Medicine · doi:10.1038/nm.2446 · Cited by 1,974

Transcriptional control of effector and memory CD8+ T cell differentiation

Kaech, S. M., & Cui, W. (2012) · Nature Reviews Immunology · doi:10.1038/nri3307 · Cited by 1,628

T Lymphocyte-Directed Gene Therapy for ADA − SCID: Initial Trial Results After 4 Years

Blaese, R. M., Culver, K. W., Miller, A. D., Carter, C. S., Fleisher, T. A., Clerici, M., Shearer, G. M., Chang, L., Chiang, Y. L., Tolstoshev, P., et al. (1995) · Science · doi:10.1126/science.270.5235.475 · Cited by 1,546

Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients

Howe, S. J., Mansour, M. R., Schwarzwaelder, K., Bartholomae, C., Hubank, M., Kempski, H., Brugman, M. H., Pike-Overzet, K., Chatters, S. J., de Ridder, D., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci35798 · Cited by 1,286

Lentiviral Hematopoietic Stem Cell Gene Therapy Benefits Metachromatic Leukodystrophy

Biffi, A., Montini, E., Lorioli, L., Cesani, M., Fumagalli, F., Plati, T., Baldoli, C., Martino, S., Calabria, A., Canale, S., et al. (2013) · Science · doi:10.1126/science.1233158 · Cited by 1,180

Correction of ADA-SCID by Stem Cell Gene Therapy Combined with Nonmyeloablative Conditioning

Aiuti, A., Slavin, S., Aker, M., Ficara, F., Deola, S., Mortellaro, A., Morecki, S., Andolfi, G., Tabucchi, A., Carlucci, F., et al. (2002) · Science · doi:10.1126/science.1070104 · Cited by 1,142

Lentiviral Hematopoietic Stem Cell Gene Therapy in Patients with Wiskott-Aldrich Syndrome

Aiuti, A., Biasco, L., Scaramuzza, S., Ferrua, F., Cicalese, M. P., Baricordi, C., Dionisio, F., Calabria, A., Giannelli, S., Castiello, M. C., et al. (2013) · Science · doi:10.1126/science.1233151 · Cited by 1,025

Gene Therapy for Immunodeficiency Due to Adenosine Deaminase Deficiency

Aiuti, A., Cattaneo, F., Galimberti, S., Benninghoff, U., Cassani, B., Callegaro, L., Scaramuzza, S., Andolfi, G., Mirolo, M., Brigida, I., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0805817 · Cited by 1,018

Gene therapy returns to centre stage

Naldini, L. (2015) · Nature · doi:10.1038/nature15818 · Cited by 1,184

T memory stem cells in health and disease

Gattinoni, L., Speiser, D. E., Lichterfeld, M. D., & Bonini, C. (2017) · Nature Medicine · doi:10.1038/nm.4241 · Cited by 657

Generation of clinical-grade CD19-specific CAR-modified CD8+ memory stem cells for the treatment of human B-cell malignancies

Sabatino, M., Hu, J., Sommariva, M., Gautam, S., Fellowes, V. S., Hocker, J. D., Dougherty, S. C., Qin, H., Klebanoff, C. A., Fry, T. J., et al. (2016) · Blood · doi:10.1182/blood-2015-11-683847 · Cited by 389

Successful and Maladaptive T Cell Aging

Goronzy, J. J., & Weyand, C. M. (2017) · Immunity · doi:10.1016/j.immuni.2017.03.010 · Cited by 362

Two subsets of stem-like CD8+ memory T cell progenitors with distinct fate commitments in humans

Galletti, G., De Simone, G., Mazza, E. M. C., Puccio, S., Mezzanotte, C., Bi, T. M., Davydov, A. N., Metsger, M., Scamardella, E., Alvisi, G., et al. (2020) · Nature Immunology · doi:10.1038/s41590-020-0791-5 · Cited by 299

Lentiviral gene therapy for X-linked chronic granulomatous disease

Kohn, D. B., Booth, C., Kang, E. M., Pai, S., Shaw, K. L., Santilli, G., Armant, M. A., Buckland, K. F., Choi, U., Ravin, S. S. D., et al. (2020) · Nature Medicine · doi:10.1038/s41591-019-0735-5 · Cited by 263

In vivo tracking of human hematopoiesis reveals patterns of clonal dynamics during early and steady-state reconstitution phases

Biasco, L., Pellin, D., Scala, S., Dionisio, F., Basso-Ricci, L., Leonardelli, L., Scaramuzza, S., Baricordi, C., Ferrua, F., Cicalese, M. P., et al. (2016) · Cell stem cell · doi:10.1016/j.stem.2016.04.016 · Cited by 243

The epigenetic control of stemness in CD8 + T cell fate commitment

Pace, L., Goudot, C., Zueva, E., Gueguen, P., Burgdorf, N., Waterfall, J. J., Quivy, J., Almouzni, G., & Amigorena, S. (2018) · Science · doi:10.1126/science.aah6499 · Cited by 232

The role of cytokines in T‐cell memory in health and disease

Raeber, M. E., Zurbuchen, Y., Impellizzieri, D., & Boyman, O. (2018) · Immunological Reviews · doi:10.1111/imr.12644 · Cited by 232

Long-lasting stem cell–like memory CD8 + T cells with a naïve-like profile upon yellow fever vaccination

Fuertes Marraco, S. A., Soneson, C., Cagnon, L., Gannon, P. O., Allard, M., Maillard, S. A., Montandon, N., Rufer, N., Waldvogel, S., Delorenzi, M., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa3700 · Cited by 206

Gene therapy targeting haematopoietic stem cells for inherited diseases: progress and challenges

Cavazzana, M., Bushman, F. D., Miccio, A., André‐Schmutz, I., & Six, E. M. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0020-9 · Cited by 205

Bone marrow central memory and memory stem T-cell exhaustion in AML patients relapsing after HSCT

Noviello, M., Manfredi, F., Ruggiero, E., Perini, T., Oliveira, G., Cortesi, F., Simone, P. D., Toffalori, C., Gambacorta, V., Greco, R., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-08871-1 · Cited by 203

New cell sources for T cell engineering and adoptive immunotherapy

Themeli, M., Rivière, I., & Sadelain, M. (2015) · Cell stem cell · doi:10.1016/j.stem.2015.03.011 · Cited by 179

Induction of a central memory and stem cell memory phenotype in functionally active CD4+ and CD8+ CAR T cells produced in an automated good manufacturing practice system for the treatment of CD19+ acute lymphoblastic leukemia

Blaeschke, F., Stenger, D., Kaeuferle, T., Willier, S., Lotfi, R., Kaiser, A. D., Assenmacher, M., Döring, M., Feucht, J., & Feuchtinger, T. (2018) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-018-2155-7 · Cited by 155

Clonal expansion of T memory stem cells determines early anti-leukemic responses and long-term CAR T cell persistence in patients

Biasco, L., Izotova, N., Rivat, C., Ghorashian, S., Richardson, R., Guvenel, A., Hough, R. E., Wynn, R. F., Popova, B., Lopes, A., et al. (2021) · Nature Cancer · doi:10.1038/s43018-021-00207-7 · Cited by 155

IL15 and T-cell Stemness in T-cell–Based Cancer Immunotherapy

Pilipow, K., Roberto, A., Roederer, M., Waldmann, T. A., Mavilio, D., & Lugli, E. (2015) · Cancer Research · doi:10.1158/0008-5472.can-15-1498 · Cited by 138

Antioxidant metabolism regulates CD8+ T memory stem cell formation and antitumor immunity

Pilipow, K., Scamardella, E., Puccio, S., Gautam, S., Paoli, F. D., Mazza, E. M. C., Simone, G. D., Polletti, S., Buccilli, M., Zanon, V., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.122299 · Cited by 136

CDK4/6 Inhibition Promotes Antitumor Immunity through the Induction of T-cell Memory

Lelliott, E. J., Kong, I. Y., Zethoven, M., Ramsbottom, K. M., Martelotto, L. G., Meyran, D., Zhu, J. J., Costacurta, M., Kirby, L., Sandow, J. J., et al. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-1554 · Cited by 129

T-cell defects in patients with ARPC1B germline mutations account for combined immunodeficiency

Brigida, I., Zoccolillo, M., Cicalese, M. P., Pfajfer, L., Barzaghi, F., Scala, S., Oleaga‐Quintas, C., Álvarez‐Álvarez, J. A., Sereni, L. P., Giannelli, S., et al. (2018) · Blood · doi:10.1182/blood-2018-07-863431 · Cited by 125

Tracking genetically engineered lymphocytes long-term reveals the dynamics of T cell immunological memory

Oliveira, G., Ruggiero, E., Stanghellini, M. T. L., Cieri, N., D’Agostino, M., Fronza, R., Lulay, C., Dionisio, F., Mastaglio, S., Greco, R., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aac8265 · Cited by 121

Improving CAR T-Cell Persistence

Pietrobon, V., Todd, L. A., Goswami, A., Stefanson, O., Yang, Z., & Marincola, F. M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910828 · Cited by 124

Dynamics of genetically engineered hematopoietic stem and progenitor cells after autologous transplantation in humans

Scala, S., Ricci, L. B., Dionisio, F., Pellin, D., Giannelli, S., Salerio, F. A., Leonardelli, L., Cicalese, M. P., Ferrua, F., Aiuti, A., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0195-3 · Cited by 116

The Single-Cell Phenotypic Identity of Human CD8+ and CD4+ T Cells

Brummelman, J., Pilipow, K., & Lugli, E. (2018) · International review of cytology · doi:10.1016/bs.ircmb.2018.05.007 · Cited by 113

Understanding T cell phenotype for the design of effective chimeric antigen receptor T cell therapies

Tantalo, D. G. M., Oliver, A. J., von Scheidt, B., Harrison, A. J., Mueller, S. N., Kershaw, M. H., & Slaney, C. Y. (2021) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2021-002555 · Cited by 112

Stem, Effector, and Hybrid States of Memory CD8+ T Cells

Lugli, E., Galletti, G., Boi, S. K., & Youngblood, B. (2019) · Trends in Immunology · doi:10.1016/j.it.2019.11.004 · Cited by 107

Gene Therapy for X-Linked Severe Combined Immunodeficiency: Where Do We Stand?

Cavazzana, M., Six, E., Lagresle-Peyrou, C., André-Schmutz, I., & Hacein-Bey-Abina, S. (2016) · Human Gene Therapy · doi:10.1089/hum.2015.137 · Cited by 106

Neonatal thymectomy reveals differentiation and plasticity within human naive T cells

van den Broek, T., Delemarre, E. M., Janssen, W. J. M., Nievelstein, R. A. J., Broen, J. C., Tesselaar, K., Borghans, J. A. M., Nieuwenhuis, E. E. S., Prakken, B. J., Mokry, M., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci84997 · Cited by 104

Twenty-Five Years of Gene Therapy for ADA-SCID: From Bubble Babies to an Approved Drug

Ferrua, F., & Aiuti, A. (2017) · Human Gene Therapy · doi:10.1089/hum.2017.175 · Cited by 109

Automated manufacture of autologous CD19 CAR-T cells for treatment of non-hodgkin lymphoma

Jackson, Z., Roe, A., Sharma, A. A., Lopes, F. B. T. P., Talla, A., Kleinsorge-Block, S., Zamborsky, K., Schiavone, J., Manjappa, S., Schauner, R., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01941 · Cited by 102

Adoptive T-cell therapy for cancer: the era of engineered T cells

Bonini, C., & Mondino, A. (2015) · European Journal of Immunology · doi:10.1002/eji.201545552 · Cited by 93

Decentralized manufacturing of anti CD19 CAR-T cells using CliniMACS Prodigy®: real-world experience and cost analysis in India

Palani, H. K., Arunachalam, A. K., Yasar, M., Venkatraman, A., Kulkarni, U., Lionel, S. A., Selvarajan, S., Korula, A., Abraham, A., George, B., et al. (2023) · Bone Marrow Transplantation · doi:10.1038/s41409-022-01866-5 · Cited by 89

Surmounting the obstacles that impede effective CAR T cell trafficking to solid tumors

Donnadieu, E., Dupré, L., Pinho, L. G., & Cotta-de-Almeida, V. (2020) · Journal of Leukocyte Biology · doi:10.1002/jlb.1mr0520-746r · Cited by 85

Improving Adoptive T Cell Therapy: The Particular Role of T Cell Costimulation, Cytokines, and Post-Transfer Vaccination

Redeker, A., & Arens, R. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00345 · Cited by 79

Clinical Applications of Gene Therapy for Primary Immunodeficiencies

Cicalese, M. P., & Aiuti, A. (2015) · Human Gene Therapy · doi:10.1089/hum.2015.047 · Cited by 80

Survival Advantage of Both Human Hepatocyte Xenografts and Genome-Edited Hepatocytes for Treatment of α-1 Antitrypsin Deficiency

Borel, F., Tang, Q., Gernoux, G., Greer, C., Wang, Z., Barzel, A., Kay, M. A., Shultz, L. D., Greiner, D. L., Flotte, T. R., et al. (2017) · Molecular Therapy · doi:10.1016/j.ymthe.2017.09.020 · Cited by 79

Reconstitution of T Cell Subsets Following Allogeneic Hematopoietic Cell Transplantation

Dekker, L., de Koning, C. C. H., Lindemans, C. A., & Nierkens, S. (2020) · Cancers · doi:10.3390/cancers12071974 · Cited by 82

Efficient recovery of potent tumour-infiltrating lymphocytes through quantitative immunomagnetic cell sorting

Wang, Z., Ahmed, S. U., Labib, M., Wang, H., Hu, X., Wei, J., Yao, Y., Moffat, J., Sargent, E. H., & Kelley, S. O. (2022) · Nature Biomedical Engineering · doi:10.1038/s41551-021-00820-y · Cited by 76

Current approaches to develop “off-the-shelf” chimeric antigen receptor (CAR)-T cells for cancer treatment: a systematic review

Aparicio, C., Acebal, C., & González‐Vallinas, M. (2023) · Experimental Hematology and Oncology · doi:10.1186/s40164-023-00435-w · Cited by 82

Human TSCM cell dynamics in vivo are compatible with long-lived immunological memory and stemness

del Amo, P. C., Lahoz-Beneytez, J., Boelen, L., Ahmed, R., Miners, K. L., Zhang, Y., Roger, L., Jones, R. E., Marraco, S. A. F., Speiser, D. E., et al. (2018) · PLoS Biology · doi:10.1371/journal.pbio.2005523 · Cited by 76

From humble beginnings to success in the clinic: Chimeric antigen receptor-modified T-cells and implications for immunotherapy

Firor, A. E., Jares, A., & Ma, Y. (2015) · Experimental Biology and Medicine · doi:10.1177/1535370215584936 · Cited by 75

The antitumor capacity of mesothelin-CAR-T cells in targeting solid tumors in mice

Zhang, Q., Liu, G., Liu, J., Yang, M., Fu, J. L., Liu, G., Li, D., Gu, Z., Zhang, L., Pan, Y., et al. (2021) · Molecular Therapy — Oncolytics · doi:10.1016/j.omto.2021.02.013 · Cited by 70

In Situ Programming of CAR T Cells

Parayath, N. N., & Stephan, M. T. (2021) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-070620-033348 · Cited by 73

Harnessing CD3 diversity to optimize CAR T cells

Cárdenas, R. M.-H. V., Brandl, S. M., Meléndez, A. V., Schlaak, A. E., Buschky, A., Peters, T., Beier, F., Serrels, B., Taromi, S., Raute, K., et al. (2023) · Nature Immunology · doi:10.1038/s41590-023-01658-z · Cited by 72

Quantitative stability of hematopoietic stem and progenitor cell clonal output in rhesus macaques receiving transplants

Koelle, S., Espinoza, D. A., Wu, C., Xu, J., Lu, R., Li, B., Donahue, R. E., & Dunbar, C. E. (2017) · Blood · doi:10.1182/blood-2016-07-728691 · Cited by 62

Immune Reconstitution Following Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis: A Review on Behalf of the EBMT Autoimmune Diseases Working Party

Cencioni, M. T., Genchi, A., Brittain, G., de Silva, T. I., Sharrack, B., Snowden, J. A., Alexander, T., Greco, R., & Muraro, P. A. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2021.813957 · Cited by 61

Cas-CLOVER is a novel high-fidelity nuclease for safe and robust generation of TSCM-enriched allogeneic CAR-T cells

Madison, B., Patil, D. P., Richter, M., Li, X., Tong, M., Cranert, S. A., Wang, X., Martin, R. M., Xi, H., Tan, Y., et al. (2022) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2022.06.003 · Cited by 61

T-cell exhaustion and stemness in antitumor immunity: Characteristics, mechanisms, and implications

Chi, X., Luo, S., Ye, P., Hwang, W., Cha, J., Yan, X., & Yang, W. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1104771 · Cited by 62

Comprehensive Approach for Identifying the T Cell Subset Origin of CD3 and CD28 Antibody–Activated Chimeric Antigen Receptor–Modified T Cells

Schmueck‐Henneresse, M., Omer, B. A., Shum, T., Tashiro, H., Mamonkin, M., Lapteva, N., Sharma, S., Rollins, L. A., Dotti, G., Reinke, P., et al. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1601494 · Cited by 57

Functional, Antigen-Specific Stem Cell Memory (TSCM) CD4+ T Cells Are Induced by Human Mycobacterium tuberculosis Infection

Mpande, C. A. M., Dintwe, O., Musvosvi, M., Mabwe, S., Bilek, N., Hatherill, M., Nemes, E., & Scriba, T. J. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00324 · Cited by 54

CRISPR-based gene disruption and integration of high-avidity, WT1-specific T cell receptors improve antitumor T cell function

Ruggiero, E., Carnevale, E., Prodeus, A., Magnani, Z. I., Camisa, B., Merelli, I., Politano, C., Stasi, L., Potenza, A., Cianciotti, B. C., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abg8027 · Cited by 58

The Role of Conditioning in Hematopoietic Stem-Cell Gene Therapy

Bernardo, M. E., & Aiuti, A. (2016) · Human Gene Therapy · doi:10.1089/hum.2016.103 · Cited by 56

Stem cell like memory T cells: A new paradigm in cancer immunotherapy

Wang, F., Cheng, F., & Fang, Z. (2022) · Clinical Immunology · doi:10.1016/j.clim.2022.109078 · Cited by 53

The Progress and Prospects of Immune Cell Therapy for the Treatment of Cancer

Han, J., Zhang, B., Zheng, S., Jiang, Y. H., Zhang, X., & Mao, K. (2024) · Cell Transplantation · doi:10.1177/09636897241231892 · Cited by 57

Progress and challenges in developing allogeneic cell therapies

Deuse, T., & Schrepfer, S. (2025) · Cell Stem Cell · doi:10.1016/j.stem.2025.03.004 · Cited by 51

Multiparameter comparative analysis reveals differential impacts of various cytokines on CART cell phenotype and function ex vivo and in vivo

Xu, X., Song, D.-G., Poussin, M., Ye, Q., Sharma, P., Rodríguez-García, A., Tang, Y., & Powell, D. J. (2016) · Oncotarget · doi:10.18632/oncotarget.10510 · Cited by 51

Effect of the mitophagy inducer urolithin A on age-related immune decline: a randomized, placebo-controlled trial

Denk, D., Singh, A., Kasler, H. G., D’Amico, D., Rey, J., Alcober-Boquet, L., Gorol, J. M., Steup, C., Tiwari, R., Kwok, R., et al. (2025) · Nature Aging · doi:10.1038/s43587-025-00996-x · Cited by 58

Stem cell-like memory T cells: The generation and application

Wang, Y., Qiu, F., Xu, Y., Hou, X., Zhang, Z., Huang, L., Wang, H., Xing, H., & Wu, S. (2021) · Journal of Leukocyte Biology · doi:10.1002/jlb.5mr0321-145r · Cited by 49

Prolonged Antiretroviral Therapy Preserves HIV-1-Specific CD8 T Cells with Stem Cell-Like Properties

Viganó, S., Negron, J., Ouyang, Z., Rosenberg, E. S., Walker, B. D., Lichterfeld, M. D., & Yu, X. G. (2015) · Journal of Virology · doi:10.1128/jvi.00789-15 · Cited by 47

T-Cell Therapy: Options for Infectious Diseases: Table 1.

Parida, S. K., Poiret, T., Zhenjiang, L., Meng, Q., Heyckendorf, J., Lange, C. G., Ambati, A., Rao, M., Valentini, D., Ferrara, G., et al. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ615 · Cited by 50

Development and Function of Protective and Pathologic Memory CD4 T Cells

Jaigirdar, S. A., & MacLeod, M. K. L. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00456 · Cited by 49

The roles of stem cell memory T cells in hematological malignancies

Xu, L., Zhang, Y., Luo, G., & Li, Y. (2015) · Journal of Hematology & Oncology · doi:10.1186/s13045-015-0214-5 · Cited by 47

Immunological history governs human stem cell memory CD4 heterogeneity via the Wnt signaling pathway

Kared, H., Tan, S. W., Lau, M. C., Chevrier, M., Tan, C. T. Y., How, W., Wong, G. C. L., Strickland, M., Malleret, B., Amoah, A., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-14442-6 · Cited by 49

Analyzing the Genotoxicity of Retroviral Vectors in Hematopoietic Cell Gene Therapy

Biasco, L., Rothe, M., Büning, H., & Schambach, A. (2017) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2017.10.002 · Cited by 45

CD4+ Memory Stem T Cells Recognizing Citrullinated Epitopes Are Expanded in Patients With Rheumatoid Arthritis and Sensitive to Tumor Necrosis Factor Blockade

Cianciotti, B. C., Ruggiero, E., Campochiaro, C., Oliveira, G., Magnani, Z. I., Baldini, M., Doglio, M., Tassara, M. G., Manfredi, A. A., Baldissera, E. M., et al. (2019) · Arthritis & Rheumatology · doi:10.1002/art.41157 · Cited by 44

Schrödinger’s T Cells: Molecular Insights Into Stemness and Exhaustion

Gonzalez, N. M., Zou, D., Gu, A., & Chen, W. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.725618 · Cited by 46

Interrupting the nitrosative stress fuels tumor-specific cytotoxic T lymphocytes in pancreatic cancer

Sanctis, F. D., Lamolinara, A., Boschi, F., Musiu, C., Caligola, S., Trovato, R., Fiore, A., Frusteri, C., Anselmi, C., Poffe, O., et al. (2022) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2021-003549 · Cited by 46

T Cell Reprogramming Against Cancer

Katz, S. G., & Rabinovich, P. M. (2019) · Methods in molecular biology · doi:10.1007/978-1-0716-0203-4_1 · Cited by 45

Effect of radiotherapy on T cell and PD-1 / PD-L1 blocking therapy in tumor microenvironment

Chen, C., Liu, Y., & Cui, B. (2021) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2020.1840254 · Cited by 43

Transfer of gene-corrected T cells corrects humoral and cytotoxic defects in patients with X-linked lymphoproliferative disease

Panchal, N., Houghton, B., Díez, B., Ghosh, S., Ricciardelli, I., Thrasher, A. J., Gaspar, H. B., & Booth, C. (2018) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2018.02.053 · Cited by 42

CD276-CAR T cells and Dual-CAR T cells targeting CD276/FGFR4 promote rhabdomyosarcoma clearance in orthotopic mouse models

Timpanaro, A., Piccand, C., Dzhumashev, D., Anton-Joseph, S., Robbi, A., Moser, J. J., Rössler, J. K., & Bernasconi, M. (2023) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-023-02838-3 · Cited by 36

Synthetic biology approaches to engineer T cells

Wu, C., Rupp, L. J., Roybal, K. T., & Lim, W. A. (2015) · Current Opinion in Immunology · doi:10.1016/j.coi.2015.06.015 · Cited by 35

Reversion Mosaicism in Primary Immunodeficiency Diseases

Miyazawa, H., & Wada, T. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.783022 · Cited by 34

Reference range of naïve T and T memory lymphocyte subsets in peripheral blood of healthy adult

Xia, Y., Liu, A., Li, W., Liu, Y., Zhang, G., Ye, S., Zhao, Z.-R., Shi, J., Jia, Y., Liu, X., et al. (2021) · Clinical & Experimental Immunology · doi:10.1093/cei/uxab038 · Cited by 34

Meeting FDA Guidance recommendations for replication-competent virus and insertional oncogenesis testing

Cornetta, K. G., Lin, T., Pellin, D., & Kohn, D. B. (2022) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2022.11.009 · Cited by 35

Hematopoiesis during Ontogenesis, Adult Life, and Aging

Belyavsky, A. V., Петинати, Н. А., & Дризе, Н. И. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179231 · Cited by 37

TIM-3, LAG-3, or 2B4 gene disruptions increase the anti-tumor response of engineered T cells

Cianciotti, B. C., Magnani, Z. I., Ugolini, A., Camisa, B., Merelli, I., Vavassori, V., Potenza, A., Imparato, A., Manfredi, F., Abbati, D., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1315283 · Cited by 32

Gene-corrected human Munc13-4–deficient CD8+ T cells can efficiently restrict EBV-driven lymphoproliferation in immunodeficient mice

Soheili, T. S., Rivière, J., Ricciardelli, I., Durand, A., Verhoeyen, E., Derrien, A., Lagresle‐Peyrou, C., Basile, G. D. S., Cosset, F., Amrolia, P. J., et al. (2016) · Blood · doi:10.1182/blood-2016-07-729871 · Cited by 29

The TRACE-Seq method tracks recombination alleles and identifies clonal reconstitution dynamics of gene targeted human hematopoietic stem cells

Sharma, R., Dever, D. P., Lee, C. M., Azizi, A., Pan, Y., Camarena, J., Köhnke, T., Bao, G., Porteus, M. H., & Majeti, R. (2021) · Nature Communications · doi:10.1038/s41467-020-20792-y · Cited by 30

The impact of inflationary cytomegalovirus‐specific memory T cells on anti‐tumour immune responses in patients with cancer

Luo, X., Meng, Q., Rao, M., Liu, Z., Paraschoudi, G., Dodoo, E., & Maeurer, M. J. (2018) · Immunology · doi:10.1111/imm.12991 · Cited by 32

Curtailed T‐cell activation curbs effector differentiation and generates CD8+ T cells with a naturally‐occurring memory stem cell phenotype

Zanon, V., Pilipow, K., Scamardella, E., Paoli, F. D., Simone, G. D., Price, D. A., Martínez-Usatorre, A., Romero, P. J., Mavilio, D., Roberto, A., et al. (2017) · European Journal of Immunology · doi:10.1002/eji.201646732 · Cited by 29

Effective control of acute myeloid leukaemia and acute lymphoblastic leukaemia progression by telomerase specific adoptive T-cell therapy

Sandri, S., Sanctis, F. D., Lamolinara, A., Boschi, F., Poffe, O., Trovato, R., Fiore, A., Sartori, S., Sbarbati, A., Bondanza, A., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.18115 · Cited by 30

Circulating hematopoietic stem/progenitor cell subsets contribute to human hematopoietic homeostasis

Quaranta, P., Ricci, L. B., Hernández, R. J., Pacini, G., Naldini, M. M., Barcella, M., Seffin, L., Pais, G., Spinozzi, G., Benedicenti, F., et al. (2024) · Blood · doi:10.1182/blood.2023022666 · Cited by 28

CAR T Cells Generated Using Sleeping Beauty Transposon Vectors and Expanded with an EBV-Transformed Lymphoblastoid Cell Line Display Antitumor Activity In Vitro and In Vivo

Chicaybam, L., Abdo, L. D. M., Carneiro, M., Peixoto, B., Viegas, M. S., de Sousa, P., Fornazin, M. C., Spago, M. C., Laranjeira, A. B. A., de Campos-Lima, P. O., et al. (2019) · Human Gene Therapy · doi:10.1089/hum.2018.218 · Cited by 27

Initiation of Antiretroviral Therapy Restores CD4 + T Memory Stem Cell Homeostasis in Simian Immunodeficiency Virus-Infected Macaques

Cartwright, E. K., Palesch, D., Mavigner, M., Paiardini, M., Chahroudi, A., & Silvestri, G. (2016) · Journal of Virology · doi:10.1128/jvi.00492-16 · Cited by 26

The construction of modular universal chimeric antigen receptor T (MU-CAR-T) cells by covalent linkage of allogeneic T cells and various antibody fragments

Chen, T., Deng, J., Zhang, Y., Liu, B., Liu, R., Zhu, Y., Zhou, M., Lin, Y., Xia, B., Lin, K., et al. (2024) · Molecular Cancer · doi:10.1186/s12943-024-01938-8 · Cited by 27

Preclinical Efficacy and Safety Evaluation of Hematopoietic Stem Cell Gene Therapy in a Mouse Model of MNGIE

Yadak, R., Cabrera-Pérez, R., Torres‐Torronteras, J., Bugiani, M., Haeck, J. C., Huston, M. W., Bogaerts, E., Goffart, S., Jacobs, E. H., Stok, M., et al. (2018) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2018.01.001 · Cited by 25

Naive and Stem Cell Memory T Cell Subset Recovery Reveals Opposing Reconstitution Patterns in CD4 and CD8 T Cells in Chronic Graft vs. Host Disease

Soares, M. V. D., Azevedo, R. I., Ferreira, I., Bucar, S., Ribeiro, A. C., Vieira, A. I. S., Pereira, P. N. G., Ribeiro, R. M., Ligeiro, D., Alho, A. C., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00334 · Cited by 27

CD40 Accelerates the Antigen-Specific Stem-Like Memory CD8+ T Cells Formation and Human Papilloma Virus (HPV)-Positive Tumor Eradication

Zhang, Y., Wang, N., Ding, M., Yang, Y., Wang, Z., Huang, L., Zhu, W., Mellor, A. L., Hou, X., Zhou, C., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01012 · Cited by 23

Early-phenotype CAR-T cells for the treatment of pediatric cancers

Meyran, D., Terry, R. L., Zhu, J. J., Haber, M., Ziegler, D. S., Ekert, P. G., Trapani, J. A., Darcy, P. K., & Neeson, P. J. (2021) · Annals of Oncology · doi:10.1016/j.annonc.2021.07.018 · Cited by 24

Nonclinical safety assessment of engineered T cell therapies

Lebrec, H. N., Maier, C. C., Maki, K., Ponce, R. A., Shenton, J. M., & Green, S. (2021) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2021.105064 · Cited by 25

CD8-positive memory T cells in tumor-draining lymph nodes of patients with breast cancer

Vahidi, Y., Bagheri, M., Ghaderi, A. A., & Faghih, Z. S. (2020) · BMC Cancer · doi:10.1186/s12885-020-6714-x · Cited by 22

Memory T Cells in the Immunoprevention of Cancer: A Switch from Therapeutic to Prophylactic Approaches

Mittra, S., Harding, S. M., & Kaech, S. M. (2023) · The Journal of Immunology · doi:10.4049/jimmunol.2300049 · Cited by 20

Genome-edited adult stem cells: Next-generation advanced therapy medicinal products

Benabdellah, K., Sánchez-Hernández, S., Aguilar-González, A., Maldonado‐Pérez, N., Gutiérrez-Guerrero, A., Cortijo-Gutierréz, M., Ramos-Hernández, I., Tristán‐Manzano, M., Galindo‐Moreno, P., Herrera, C., et al. (2020) · Stem Cells Translational Medicine · doi:10.1002/sctm.19-0338 · Cited by 21

Haematopoietic stem cell transplantation for severe autoimmune diseases in children: A review of current literature, registry activity and future directions on behalf of the autoimmune diseases and paediatric diseases working parties of the European Society for Blood and Marrow Transplantation

Achini, F., Snowden, J. A., Corbacioglu, S., Greco, R., & Parties, T. E. A. D. (. A. P. D. (. W. (2022) · British Journal of Haematology · doi:10.1111/bjh.18176 · Cited by 19

Efficient derivation of chimeric-antigen receptor-modified TSCM cells

Kranz, E. O., Kuhlmann, C. J., Chan, J., Kim, P. Y., Chen, I. S. Y., & Kamata, M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.877682 · Cited by 18

Tissue‐resident and memory properties of human T‐cell and NK‐cell subsets

Lugli, E., Hudspeth, K. L., Roberto, A., & Mavilio, D. (2016) · European Journal of Immunology · doi:10.1002/eji.201545702 · Cited by 20

Characterizing Hepatitis C Virus–Specific CD4+ T Cells Following Viral‐Vectored Vaccination, Directly Acting Antivirals, and Spontaneous Viral Cure

Hartnell, F., Esposito, I., Swadling, L., Brown, A., Phetsouphanh, C., de Lara, C., Gentile, C., Turner, B., Dorrell, L., Capone, S., et al. (2020) · Hepatology · doi:10.1002/hep.31160 · Cited by 18

Allogeneic gene-edited HIV-specific CAR-T cells secreting PD-1 blocking scFv enhance specific cytotoxic activity against HIV Env+ cells in vivo

Pan, H., Yang, X., Wang, J., Liang, H., Jiang, Z., Zhao, L., Wang, Y., Liang, Z., Shen, X., Lin, Q., et al. (2023) · Virologica Sinica · doi:10.1016/j.virs.2023.01.003 · Cited by 19

Integrating Vectors for Gene Therapy and Clonal Tracking of Engineered Hematopoiesis

Biasco, L., Rothe, M., Schott, J. W., & Schambach, A. (2017) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2017.06.009 · Cited by 17

T cell gene therapy to treat immunodeficiency

Panchal, N., Ghosh, S., & Booth, C. (2020) · British Journal of Haematology · doi:10.1111/bjh.17070 · Cited by 18

Long-term tracking of transplanted T cells

Colmone, A. C. (2015) · Science · doi:10.1126/science.347.6222.623-e

T cell therapies-are T memory stem cells the answer?

Flynn, J. K., & Gorry, P. R. (2015) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2305-5839.2015.08.13 · Cited by 8

Tracking genetically engineered lymphocytes long-term reveals the dynamics of T cell immunological memory

Oliveira, G., Ruggiero, E., Stanghellini, M. T. L., Cieri, N., D’Agostino, M., Fronza, R., Lulay, C., Dionisio, F., Mastaglio, S., Greco, R., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aac8265 · Cited by 121

Immune cell tracking following hematopoietic cell and gene therapy

Izotova, N. (2022) · UCL Discovery (University College London)

Human TSCM cell dynamics in vivo are compatible with long-lived immunological memory and stemness

del Amo, P. C., Lahoz-Beneytez, J., Boelen, L., Ahmed, R., Miners, K. L., Zhang, Y., Roger, L., Jones, R. E., Marraco, S. A. F., Speiser, D. E., et al. (2018) · PLoS Biology · doi:10.1371/journal.pbio.2005523 · Cited by 76